Rui Lin

Rui Lin

Director/Board Member presso Fidelity Asia Ventures Ltd. (Shanghai)

53 anni
Health Technology
Finance
Health Services

Profilo

Rui Lin is currently the Vice Chairman at Changzhou Bioregen Biological Pharmaceuticals Co., Ltd., Director at Sipai (Beijing) Network Technology Co., Ltd., Director at Beijing Meizhong Airui Cancer Hospital Co., Ltd., and Partner at Eight Roads Capital Advisors (Hong Kong) Ltd.
She previously held the position of Vice President at Fidelity Asia Ventures Ltd.
(Shanghai).
Ms. Lin's former positions include Director at Zhejiang Boner Medical Investment Management Co., Ltd., Director at YS Biopharma Co. Ltd., and Member-Supervisory Board at Shanghai Hile Bio-Technology Co., Ltd.
Ms. Lin received an MBA from The Wharton School of the University of Pennsylvania in 2000.

Posizioni attive di Rui Lin

SocietàPosizioneInizio
Director/Board Member 01/01/2007
Director/Board Member -
Private Equity Investor -
Director/Board Member -
Director/Board Member 03/12/2020
Tutte le posizioni attive di Rui Lin

Precedenti posizioni note di Rui Lin

SocietàPosizioneFine
Director/Board Member -
YS BIOPHARMA CO., LTD. Director/Board Member -
SHANGHAI HILE BIO-TECHNOLOGY CO., LTD. Director/Board Member -
Vedi nel dettaglio l'esperienza di Rui Lin

Formazione di Rui Lin

The Wharton School of the University of Pennsylvania Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Rui Lin

Relazioni

100 +

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
SHANGHAI HILE BIO-TECHNOLOGY CO., LTD.

Health Technology

YS BIOPHARMA CO., LTD.

Health Technology

Aziende private6

Finance

Finance

Health Technology

Health Services

Technology Services

Health Services

Vedi le connessioni aziendali